Grant: Discovery Grants Program - Individual
University of British Columbia
$20,000.00
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
EF 2011-12
Résumé
The application of nanotechnology to drugs, referred to as ""nanomedicines"" has a high potential for technological and conceptual breakthroughs. The development of nano-sized drug delivery systems will ultimately allow us to target selected cells or tissues within the body and control the release of drug at that site, resulting in greater safety and effectiveness of the administered drug. The overall goal of this proposal is to develop novel, tumor site-directed nanoparticles for the local treatment of disease with either chemotherapeutic agents or cell-killing by heat. Our initial focus will be the synthesis, preparation and characterization of nanoparticles made of tissue-compatible polymers and loaded with the anticancer drugs, paclitaxel and cisplatin, for potential application in bladder cancer. Most patients with this cancer have superficial disease, affecting just the surface lining of the bladder wall. Current chemotherapy treatments using drugs instilled directly into the bladder are not very effective because the contact time of the drug with the bladder wall is only about 2 hours, before voiding occurs. We believe that modifying the surfaces of the drug nanoparticles with tissue-adhering groups should prolong the contact time, increase uptake of drug into the tissue, increase effectiveness and potentially decrease unwanted side effects. We have assembled an outstanding team of collaborators who will develop, for example, nanoparticles that can co-deliver two drugs and nanoparticles with a gold coating that can be irradiated with light of a certain wavelength and will heat up and kill cancer cells.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
311940-2009
Name nom
Burt, Helen
Department département
Pharmaceutical Sciences, Faculty of
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
20000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2004
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Polymers and coatings
Research subject fr
Polymères et revêtements
Partie
3
Nb partie
5
Application title
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
Keyword
NSERC
Application summary
The application of nanotechnology to drugs, referred to as ""nanomedicines"" has a high potential for technological and conceptual breakthroughs. The development of nano-sized drug delivery systems will ultimately allow us to target selected cells or tissues within the body and control the release of drug at that site, resulting in greater safety and effectiveness of the administered drug. The overall goal of this proposal is to develop novel, tumor site-directed nanoparticles for the local treatment of disease with either chemotherapeutic agents or cell-killing by heat. Our initial focus will be the synthesis, preparation and characterization of nanoparticles made of tissue-compatible polymers and loaded with the anticancer drugs, paclitaxel and cisplatin, for potential application in bladder cancer. Most patients with this cancer have superficial disease, affecting just the surface lining of the bladder wall. Current chemotherapy treatments using drugs instilled directly into the bladder are not very effective because the contact time of the drug with the bladder wall is only about 2 hours, before voiding occurs. We believe that modifying the surfaces of the drug nanoparticles with tissue-adhering groups should prolong the contact time, increase uptake of drug into the tissue, increase effectiveness and potentially decrease unwanted side effects. We have assembled an outstanding team of collaborators who will develop, for example, nanoparticles that can co-deliver two drugs and nanoparticles with a gold coating that can be irradiated with light of a certain wavelength and will heat up and kill cancer cells.